Jennifer E. Cook, Director at BridgeBio Pharma, Inc. (BBIO), sold 39,363 shares at $68.57 ($2.8M) on 2026-06-23, disclosed to the SEC on 2026-06-24.
Scheduled sale ($2.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.57 | 2,196 | $151K | 5.5% |
| 2 | $70.00 | 37,167 | $2.6M | 94.5% |
| Total | $69.92 avg | 39,363 | $2.8M | 100% |
| Filing → |
| DNLI | SELL | 2024-06-10 | $32K | — | Filing → |
| JAZZ | SELL | 2023-12-06 | $50K | — | Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |